Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (2)
  • 2023 (1)
  • 2022 (1)
  • 2019 (1)

Subject

  • Drug Trafficking (49)
  • Arrests/Convictions - Major (46)
  • Overdose (37)
  • Take Back Day (24)
  • Fake Pills (19)
  • Prescription Drugs (16)
  • Fentanyl Awareness (13)
  • OCDETF/Task Force (11)
  • Pharmaceuticals/Pharmacists/Physicians (10)
  • Synthetic drugs (10)
  • Guilty Plea (9)
  • Major Law Enforcement Operation (9)
  • Money Laundering (9)
  • Seizures (Drugs/Property) (8)
  • Extraditions (6)
  • Guns/Weapons (6)
  • Outreach/Drug Prevention (6)
  • Task Forces/Task Force Officers (4)
  • Prevention/Education - DEA websites GSAD, JTT etc (3)
  • Narcoterrorism (2)
  • One Pill Can Kill (2)
  • Red Ribbon (2)
  • Campaigns (1)
  • Congressional Affairs (1)
  • Dark Web- Internet Trafficking (1)
  • Fentanyl Free America (1)
  • Intergovernmental Affairs (1)
  • Diversion Division (5)

Field Division

  • Washington, DC (34)
  • New England (33)
  • New York (23)
  • Seattle (22)
  • Chicago (18)
  • Houston (15)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (9)
  • New Orleans (8)
  • Sede (8)
  • San Francisco (7)
  • St. Louis (7)
  • El Paso (6)
  • Dallas (5)
  • Rocky Mountain (5)
  • Los Angeles (3)
  • Omaha (3)
  • Phoenix (3)
  • Detroit (1)
  • San Diego (3)
  • Louisville (2)
Clear All Results
PRESS RELEASE

OptumRx Agrees to Pay $20M to Resolve Allegations that It Filled Opioid Prescriptions in Violation of the Controlled Substances Act

Junio 27, 2024
SAN DIEGO – OptumRx Inc., a prescription drug benefit provider, has agreed to pay $20 million to resolve allegations that it improperly filled certain opioid prescriptions in violation of the Controlled Substances Act. The settlement resolves an investigation initiated by the Drug Enforcement Administration (DEA) into whether, between April 2013...
Junio 27, 2024
PRESS RELEASE

Palomar Hospital Pays $250,000 for Diverting Fentanyl

Junio 03, 2024
SAN DIEGO – Palomar Health, a California public health care district located in San Diego County, has paid $250,000 to resolve allegations of diversion of fentanyl from one of its facilities and failure to keep accurate records for fentanyl. Palomar Health is California’s largest health care district, with campuses in...
Junio 03, 2024
PRESS RELEASE

DEA to host summit on Medication for Opioid Use Disorder (MOUD) in Charleston, WV

Abril 04, 2023
Louisville, Ky. – The Drug Enforcement Administration (DEA) and the State of West Virginia are hosting a discussion on Medication for Opioid Use Disorder (MOUD) in Charleston, West Virginia on Saturday, April 15, 2023 from 12:00 p.m. to 5:00 p.m. The event will take place at the University of Charleston’s...
Abril 04, 2023
PRESS RELEASE

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl

Diciembre 16, 2022
SAN DIEGO - Dr. David J. Smith, a pain management physician, and his office manager, Julia Ann Oertle, are charged in a federal grand-jury indictment with perpetuating a long-running scheme to commit healthcare fraud and to manufacture and distribute adulterated fentanyl. Smith made his initial appearance today before U.S. Magistrate...
Diciembre 16, 2022
PRESS RELEASE

DEA to host free Rx prescriber conference

Marzo 19, 2019
LOUISVILLE, Ky. - The United States Drug Enforcement Administration today announced that it will be hosting a regional Practitioner Diversion Awareness Conference (PDAC) on March 27, 2019. The PDAC is designed to educate and assist doctors, veterinarians, dentists, physician assistants, and nurse practitioners across the Commonwealth of Kentucky in identifying...
Marzo 19, 2019
Showing 1 - 5 of 5 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster